All In Biotech

Drug Trial Radar · NCT04353778

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

215

Actual

Start

Aug 3, 2020

Primary completion

Mar 27, 2026

Study completion Mar 27, 2026

Sponsor

Lead sponsor
Icahn School of Medicine at Mount SinaiAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Apr 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that SIBO is associated with signs of inflammation in the blood of people living with HIV (PLWH). This research will explore pathways linking vagal dysfunction to inflammation in HIV, focusing on the gastrointestinal tract, and study whether a medication called pyridostigmine and stimulation of the vagus nerve are beneficial therapies.

Conditions

  • HIV
  • Non-HIV
  • Vagus Nerve Dysfunction

Interventions

  • PyridostigmineDrug

    Eight weeks of low-dose pyridostigmine

  • PlacebosDrug

    matching placebo x 8 weeks

  • non-invasive vagal nerve stimulationProcedure

    stimulation of the vagus nerve

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Small bowel transit time (SBTT)Time frame: 8 weeks
  2. Gastric pH measurementTime frame: 8 weeks
  3. Hydrogen/methane breath testing (hbt)Time frame: 8 weeks
  4. IL6 measurement [Time Frame: 5 years]Time frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Icahn School of Medicine at Mount Sinai

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.